Adalimumab-Adaz (Subcutaneous Route)
Name: Adalimumab-Adaz (Subcutaneous Route)
- Adalimumab-Adaz Subcutaneous Route brand name
- Adalimumab-Adaz Subcutaneous Route injection
- Adalimumab-Adaz Subcutaneous Route used to treat
- Adalimumab-Adaz Subcutaneous Route is used to treat
- Adalimumab-Adaz Subcutaneous Route uses
- Adalimumab-Adaz Subcutaneous Route side effects
- Adalimumab-Adaz Subcutaneous Route missed dose
US Brand Name
Adalimumab-adaz injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing spondylitis. It is used in children 4 years of age and older for juvenile idiopathic arthritis. This medicine is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-adaz may be used alone or in combination with other medicines (eg, methotrexate).
Adalimumab-adaz injection is also used to treat the symptoms of active Crohn's disease in adult patients who have not been helped by other medicines, including infliximab. It is also used to treat moderate to severe ulcerative colitis in patients who have been treated with other medicines (eg, azathioprine, corticosteroids, or 6-mercaptopurine) that did not work well.
Adalimumab-adaz injection is also used to treat moderate to severe chronic plaque psoriasis, which is a skin disease with red patches and white scales that do not go away.
This medicine is available only with your doctor's prescription.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of adalimumab-adaz injection for the treatment of juvenile idiopathic arthritis in children 4 years of age and older. However, safety and efficacy have not been established in children younger than 2 years of age or weighing less than 10 kilograms (kg) for juvenile idiopathic arthritis. Safety and efficacy have not been established for other uses in children.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
- Blood problems (eg, aplastic anemia, pancytopenia, thrombocytopenia), history of or
- Congestive heart failure or
- Guillain-Barré syndrome, history of or
- Infections (fungal, bacterial), history of or
- Leukopenia (low number of white blood cells) or
- Multiple sclerosis or
- Optic neuritis (eye problem) or
- Psoriasis (skin disease)—Use with caution. May make these conditions worse.
- Cancer, active or history of or
- Chronic obstructive pulmonary disease (COPD)—Use with caution. May increase the chance of getting new cancers.
- Diabetes or
- Hepatitis B, history of or
- Opportunistic infections, history of or
- Tuberculosis, history of—May increase chance for side effects.
- Infection, active—Should not be used in patients with this condition.
- Tuberculosis, active—Should be treated first before receiving this medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Store in the refrigerator. Do not freeze.
Keep it in its original container. Protect from light. You may also store this medicine at room temperature for up to 14 days. Do not store it in extremely cold or hot temperatures. Throw away any unused medicine after 14 days.
Throw away used syringes or pens in a hard, closed container that the needles cannot poke through. Keep this container away from children and pets.